Representatives, Donna Shalala and Matt Gaetz have supposedly introduced a bipartisan bill that aims to find ways to reschedule cannabis, as it currently prevents researchers from studying the effectiveness of the plant’s numerous cannabinoids.
To be more specific, the Expanding Cannabis Research and Information Act is working towards de-scheduling cannabis from Schedule I of the Controlled Substances Act and instead putting it under Schedule III reports Grizzle.
The latter approach is expected to lighten researchers’ barrier to studying the plant, especially if it means that disputes between the federal government and states that have legalized medical cannabis use is surely to drop.
Shalala, who has been formerly known for taking on as the secretary of Health and Human Services, has since expressed the importance of understanding cannabis with respect to consumer wellness and how crucial it is for said findings to be concluded in the safest possible manner.
In particular, Shalala said:
“We are not only bringing federal cannabis policy […] but we’re also guaranteeing that we do so safely.”
The duo’s alliance doesn’t come too much of a surprise, as they are for changing the negative perspective of cannabis. While Shalala’s had a recent change of heart, Gaetz has always been putting in effort in order to make cannabis research possible so that both short and long-term benefits could be understood.
The Condor CBD Gummies have been the talk of the hemp-derived cannabidiol edibles as of…
Delta 8 THC is a naturally occurring cannabinoid commonly produced from hemp-derived CBD. It’s relatively…
With more people turning towards natural remedies in recent years, mushroom supplements have taken the…
The Circle Labs CBD Balm is extracted using a cold-infusion process and is an effective…
If anyone is looking for a CBD supplement that is packed with all the necessary…
If anyone has been searching the internet for all the benefits of CBD and where…